Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122150703 | 12215070 | 3 | F | 201601 | 20160919 | 20160328 | 20160927 | EXP | IE-JNJFOC-20160321626 | JANSSEN | 71.04 | YR | E | F | Y | 0.00000 | 20160927 | OT | IE | IE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122150703 | 12215070 | 1 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | FDS0VMY;FES09NB | 0 | 45 | MG | SOLUTION FOR INJECTION | ||||||
| 122150703 | 12215070 | 2 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | FDS0VMY;FES09NB | 0 | 45 | MG | SOLUTION FOR INJECTION | ||||||
| 122150703 | 12215070 | 3 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | FDS0VMY;FES09NB | 0 | 45 | MG | SOLUTION FOR INJECTION | ||||||
| 122150703 | 12215070 | 4 | PS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | FDS0VMY;FES09NB | 125261 | 45 | MG | SOLUTION FOR INJECTION | ||||||
| 122150703 | 12215070 | 5 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | D | 0 | 5 | MG | UNSPECIFIED | QD | ||||||
| 122150703 | 12215070 | 6 | C | COBALAMIN | COBALAMIN | 1 | Unknown | D | 0 | 1 | MG | UNSPECIFIED | QD | ||||||
| 122150703 | 12215070 | 7 | C | NEOMERCAZOLE | CARBIMAZOLE | 1 | Unknown | D | 0 | 5 | MG | UNSPECIFIED | BID | ||||||
| 122150703 | 12215070 | 8 | C | CELEBREX | CELECOXIB | 1 | Unknown | D | 0 | 200 | MG | UNSPECIFIED | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122150703 | 12215070 | 1 | Psoriasis |
| 122150703 | 12215070 | 2 | Psoriasis |
| 122150703 | 12215070 | 3 | Psoriasis |
| 122150703 | 12215070 | 4 | Psoriasis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122150703 | 12215070 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122150703 | 12215070 | Hyperthyroidism | |
| 122150703 | 12215070 | Off label use | |
| 122150703 | 12215070 | Product use issue | |
| 122150703 | 12215070 | Psoriasis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122150703 | 12215070 | 1 | 20150903 | 0 | ||
| 122150703 | 12215070 | 2 | 20160321 | 0 | ||
| 122150703 | 12215070 | 3 | 20160815 | 0 | ||
| 122150703 | 12215070 | 4 | 201601 | 0 |